🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy, safety, and tolerabili...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-07
Trial ID
NCT01399125
To study the effects of treatment with rivastigmine on craving produced by ...
Status
Completed
Location
Michael E. DeBakey VA Medical Center
Start Date
2009-07
Trial ID
NCT01073319
Treatments Being Tested
This study is being conducted to determine the safety, tolerability, and ph...
Status
Completed
Location
Pacific Research Network, Inc.
Start Date
2008-10
Trial ID
NCT00766363
Rivastigmine is a carbamate, approved by the FDA for the treatment of mild ...
Status
Completed
Location
Tasmc Clinical Research Center
Start Date
2009-01
Trial ID
NCT00624663
Treatments Being Tested
The study is a 24-week prospective, double blind, randomized, placebo-contr...
Status
Completed
Location
Singapore General Hospital
Start Date
2006-02
Trial ID
NCT00669344
Treatments Being Tested
The purpose of this multicenter trial is to assess the efficacy and safety ...
Status
Terminated
Location
Multiple Locations
Start Date
2013-10-22
Trial ID
NCT01852110
Rationale: Visual hallucinations (VH) are the most common non-motor symptom...
Status
Terminated
Location
Academic Medical Center
Start Date
2013-11
Trial ID
NCT01856738
Treatments Being Tested
Auditory hallucinations are among the most distressing aspects of psychotic...
Status
Recruiting
Location
Connecticut Mental Health Center
Start Date
2021-07-15
Trial ID
NCT04366518
Treatments Being Tested
The objective of this 3-month study is to assess the safety and efficacy of...
Status
Completed
Location
Hôpital Privé Les Magnolias
Start Date
2008-04
Trial ID
NCT00880412
Treatments Being Tested